Performance Measurement Network

Question: STK-6 Data Entry in CMIP for Q1 2010

This is follow up to a prior question: "Is intensive dosing of statin required to meet STK-6?";.

It is my understanding that the measure specifications for STK-6 changed to Dishcarged on Statin Medication as of January 2010. However, the measure name in CMIP is still Discharged on Cholesterol-Reducing Therapy. Which set of data should be entered for Q1 2010 (Jan, Feb, Mar)?


Effective January 1, 2010, all certified PSCs should be collecting data for STK-6 "Discharged on Statin Medication" per the specifications as outlined in the specifications manual, version 3.0c. STK-6 data entered in CMIP for Q1 2010 should be for statin medications only.

Modifications to the CMIP application are currently being made to reflect the STK-6 name change to statins. The deadline for Q1 2010 stroke data submission to the Joint Commission is May 15th.

Question Details
Focus area(s): Chart Abstracted Measure Specifications – Clinical
Related documents: STK, STK 6 Statin,

Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Performance Measurement Network? Send feedback
This website is using cookies. More info. That's Fine